Philip Tsai - Jun 17, 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Technology Officer
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Jun 17, 2024
Transactions value $
$0
Form type
4
Date filed
6/18/2024, 09:08 PM
Next filing
Nov 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +250K $0.00 250K Jun 17, 2024 Common Stock 250K $13.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on June 17, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.